Search - tctmd.com

Displaying 621 - 640 of 879

Sort: Relevancy | Date

Presentation TCT 2014

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Presenter: Giulio Stefanini

September 16, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

Presentation TCT 2014

Endothelialization of the Multilayer Flow Modulator Versus Single-Layer Arterial Stents

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Choice of Metallic DES Stents for Bifurcation Stenting

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Francesco Burzotta

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Presenter: Valentin Fuster, Patrick W. Serruys, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Advertisement

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Endothelialization of the Multilayer Flow Modulator Versus Single-Layer Arterial Stents

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Choice of Metallic DES Stents for Bifurcation Stenting

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

COMBO Stent Achieves Neointimal Regression at 24 Months

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content